t*******o
发帖数: 1464 | 1 Prana Biotechnology Limited Announces Publication Of New Analysis In Journal
Of Alzheimer's Disease
11:10am EDT
Prana Biotechnology Limited announced that the Journal of Alzheimer's
Disease, published an article on April 19 about Prana's lead drug candidate
for Alzheimer's disease, PBT2, providing new analysis that it is effective
in reversing dementia symptoms. The analysis, conducted by Professor Ashley
Bush of The Mental Health Research Institute and The University of Melbourne
, Australia, i... 阅读全帖 |
|
c*****j
发帖数: 92 | 2 Ten-Bagger Chase Goes After Prana (PRAN)
April 19, 2010 · Filed Under Financial, alzheimer's
Prana Biotechnology Ltd. (NASDAQ: PRAN) is up over 100% today on some
published data. The share trading activity is indicative of traders and
investors looking for the next biotech ten-bagger, or that search for a 1,
000% Gainer.
The report causing the run-up is new published analysis of its clinical
trial excerpt taken from the Journal of Alzheimer’s Disease.
The publication published an article about ... 阅读全帖 |
|
c*****j
发帖数: 92 | 3 看起来PBT2很牛啊，PBT2 is effective in reversing dementia symptoms. To date
, all market-approved
Alzheimer’s and dementia drugs are aimed to slow the progression of the
disease. |
|
c*****j
发帖数: 92 | 4 新文章的新内容在于量化了效果的百分比
This new analysis has adjusted for this and demonstrated that: 81% of
patients on the 250mg dose of PBT2 responded better on the Executive Factor
NTB score than the performing patient on placebo. 41% of patients on the
250mg dose of PBT2 responded better on the overall Composite NTB score than
the performing patient on placebo. |
|
